Skip to main content
. 2021 Nov 17;1(3):oeab039. doi: 10.1093/ehjopen/oeab039

Figure 3.

Figure 3

Changes in plaque geometric parameters or plaque constituents after control or high-intensity statin treatment. Change in (A) plaque geometric parameters including external elastic membrane area, plaque area and plaque burden, (B) necrotic core area and % or dense calcium area and %, and (C) fibrofatty area and % or fibrous tissue area and % in control or high-intensity statin-treated patients. Data are mean (standard error) between baseline and follow-up using mixed-effects models.